Inactive

Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0086. Naval Medical Center San Diego (NMCSD... Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0086. Naval Medical Center San Diego (NMCSD) intends to award a firm fixed price sole source contract under the authority of FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to: Ortho Clinical Diagnostics K. K. 1-11-2 Osaki Gate City Osaki East Tower 16F. Shinagawa-ku, Tokyo 141, Japan The North American Industry Classification System (NAICS) code for this requirement is 325413; the business size standard is 1250 (# of employees). The objective of this sole source award is to provide the following supplies: A/BID Mono & Reverse Group Card (5x20) MTS Buffered Gel Card (5x20) A/BID Mono Group Card (5x20) Anti-IgG Card (5x20) 0.8% Affirmagen (2xl0ml) Alba Q Chek simulated whole blood controls 0.8% Pooled screen (2xl0ml) Ortho 7% BSA Ortho Clinical Diagnostics is the Original Equipment Manufacturer (OEM) of ASBBC's vision hematology analyzer and sole proprietor of the requested reagents currently in use at Naval Medical Center San Diego and Ortho Clinical Diagnostics is the only provider who can provide the supplies needed with the above stated characteristics. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the supplies validated by Ortho Clinical Diagnostics. Capability statements shall not exceed 6 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 1500 Pacific Time, 14 Sep 2021. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: dernell.w.wade.civ@mail.mil. The email subject line shall state, “Naval Medical Center San Diego, Special Notice Number N0025921N0086.” NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED